PDF (572kB) - Nur für Mitarbeiter des Archivs |
- DOI zum Zitieren dieses Dokuments:
- 10.5283/epub.1031
Zusammenfassung
Human tumors frequently escape immune destruction, despite the presence of cytotoxic T cells (CTL) recognizing tumor-associated antigens (TAA). We have previously shown that programmed death ligand-1 (PD-L1), a recently identified ligand of the B7 superfamily, is expressed on murine tumors and can inhibit antitumor immune responses. To evaluate the clinical relevance of our animal model findings, ...
Nur für Besitzer und Autoren: Kontrollseite des Eintrags